← FDA Drug Approvals (Drugs@FDA)

OFLOXACIN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: MICRO LABS · Approved 2026-04-08

Drug application

FDA Application #

ANDA218557

Application type

Abbreviated New Drug Application (Generic)

Brand name

OFLOXACIN

Generic name

Ofloxacin

Active ingredients

OFLOXACIN

Dosage form

SOLUTION/DROPS

Route

OPHTHALMIC

Marketing status

Prescription

Sponsor

MICRO LABS

First approval

2026-04-08

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown